|
S.N. |
Name of Author/s |
Title of Publication |
Journal Name |
Vol., Year |
Indexed/IF |
|---|---|---|---|---|---|
| 1 | Rahul D. Jawarkar, Anam Khan | Targetting PI3K-AKT-mTOR signaling pathway in non-small cell lung carcinoma: Exploring promissing bioactive natural compounds as anti-cancer agents | Chemical Physics Impact | 2025, 100793 | 3.8 |
| 2 | Ms. Samilsha Hamane, Dr. Pramod V. Burkale, Dr. Prashant Ajmire, Ms. Mansi Nikhade | The multifaceted approch to polycystic ovarian synderome: A review of traditional and allopathic medicine | International Journal Of Research Trends and Innovation | Volume 10, June 2025 | Scopus Indexed |
| 3 | Ms. Mansi Nikhade, Prof. Sagar Ande, Dr. Pramod V. Burkale |
Preclinical models of parkinson’s disease: tools for understanding and advancing neuroprotective strategies |
World Journal of Pharmaceutical and Medical Research | July 9, 2025 | Scopus Indexed |
| 4 | Tushar V. Bhatkar, Dr. Pramod V. Burkale, Dr. Prashant Ajmire, Ashish Wadekar | The UV Spectroscopic method was developed and validated to estimate the concentration of Remogliflozin Etabonate in Pharmaceutical Dosage form | Journal of Civil and Environmental Engineering | 2025 (13), 1 | Scopus |
| 5 | Rahul D. Jawarkar | Synergizing GA-XG Boost and QSAR modeling: Breaking down activity aliffs in HDAC1 inhibitors | Journal of Molecular Graphics and Modelling | 2025, 108915 | 2.7 |
| 6 | Dr. Snehal S. Manekar | Formulation, Characterisation and In Vitro evaluation of Herbosome Sunscreen Lotion | International Journal of Ayurvedic Medicines | Vol. 16 No. 1 (2025): January - March 2025 | 1.56 |
| 7 | Tushar V. Bhatkar, Dr. Pramod V. Burkale | Quality by Design based dissolution test development of metformin immediate and extended release tablet formulation | Journal of Civil and Environmental Engineering | 2025 (13), 1 | Scopus |
| 8 | Rahul D. Jawarkar | Analyzing Oxygen Atom Distribution in FDA Approved Drugs to Enhance Drug Discovery Strategies | Chemical biology & drug design | 2025, e70060 | 3.2 |
| 9 | Rahul D. Jawarkar | Py Descriptor C: A Descriptor Calculation Tool for Decoding Chirality Cliffs and Revealing Hidden Patterns in Drug Discovery | ChemRxiv | 2025 | Scopus |
| 10 | Rahul D. Jawarkar | Investigating the role of natural flavonoids in VEGFR inhibition: Molecular modelling and biological activity in A549 lung cancer cells | Journal of Molecular Structure | 2025, 140392 | 4.0 |
| 11 | Rahul D. Jawarkar | Identification of pharmacophore synergism for optimization of estrogen receptor beta binders for hormone dependent forms of breast cancer | Chemical Physics Impact | Volume 10, June 2025, 100872 | 3.8 |
| 12 | Rahul D. Jawarkar | Synthesis, in vitro, and in silico studies of 7-fluorochromone based thiosemicarbazones as α-glucosidase inhibitors | Nature Scientific Reports | March 2025, 9816 (2025) | 4.2 |
| 13 | Rahul D. Jawarkar | In vitro and in sillico analysis of synthesized N-benzyl indole-derived hydrazones as potential anti-triple negative breast cancer agents. | RCS Advances | Issue 17, 2025 | 3.9 |
| 14 | Rahul D. Jawarkar | Synthesis, Anti‐Alzheimer Evaluation and In Silico Study of 4‐Methoxyphenyl) Sulfonyl Indole Hybrid Thiosemicarbazones |
Archiv der Pharmazie |
2025; e70034 |
3.6 |
| 15 | Rahul D. Jawarkar | Py Descriptor C: A Descriptor Calculation Tool for Decoding Chirality Cliffs and Revealing Hidden Patterns in Drug Discovery |
RHAZES: Green & Applied Chemistry |
2605-6895 Vol. 21, 2025 | Scopus |
| 16 | Rahul D. Jawarkar |
Synthesis, human carbonic anhydrase I and II inhibition, and in silico studies of 2-ethoxy-6-formylphenyl [1,1′-biphenyl]-4-sulfonate derived thiosemicarbazones |
Bioorganic Chemistry |
Volume 164, September 2025, 108836 | 4.7 |
| 17 | Rahul D. Jawarkar |
Design and synthesis of pyridazinone hybrid in PEG‑400 as COX‑1/ COX‑2 inhibitor and their antioxidant study |
Discover Chemistry |
(2025) 2:142 |
Scopus |
| 18 |
Ashish B. Wadekar |
Comment on “Complementary Roles of PCT, CRP, WBC, and ΔWBC in Early Leak Detection After Bariatric Surgery: A Retrospective Pilot Study”. |
Obesity Surgery |
Sept. 2025 | 3.1 |
| S.N. | Name of Author/s | Title of Publication | Journal Name | Vol., Year | Indexed/IF |
|---|---|---|---|---|---|
| 1 | Dr. Pravin N. Khatale | Reverse phase, ion exchange, HILIC and mix-mode chromatography for the determination of metformin and evogliptin in human plasma and pharmaceutical formulations | Talanta Open; (ISSN: 26668319) | (2024), 9:100274 | 4.6 |
| 2 | R.D. Jawarkar | In-silico QSAR Modeling for Identification of Novel Anticancer Agent as Anaphylactic Lymphoma Kinase Inhibitor | Phys. Chem. Res; (e-ISSN: 2345-2625) | 2024, Vol. 12, No. 3, 591-620, | 1.28 |
| 3 | R.D. Jawarkar | QSAR and docking based lead optimization of nitrogen heterocycles for enhanced prostaglandin EP2 receptor agonistic potency | Chemical Physics Impact (ISSN 2667-0224) | 2024, Vol. 8, 100484 | 2.5 |
| 4 | Dr. Pravin N. Khatale, Dr. Pramod V. Burakale, Rahul D. Jawarkar | Application of in-silico drug discovery techniques to discover a novel hit for targetspecific inhibition of SARS-CoV-2 Mpro’s revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder | PLOS ONE, (e ISSN: 1932-6203) | 2024 | 3.75 |
| 5 | Dr. Pravin N. Khatale, Dr. Pramod V. Burakale, Rahul D. Jawarkar, Anam N. Khan, Dhanashree Bhagat | Molecular Docking, QSAR, and ADME Studies of Some Pyrrolo[1,2-a] benzimidazole-based quinones as Novel Topoisomerase 2 beta (TOP2β) Inhibitors | Chemical Physics Impact (ISSN: 2667-0224) | 2024 | 2.5 |
| 6 | R.D. Jawarkar | A decade review of analysis of essential oils from genus Artocarpus Its phytochemistry and pharmacology | Pharmacological Research - Natural Products (ISSN 2950-1997) | 2024, 2 (100016) | 2.7 |
| 7 | Tushar Bhatkar, Pramod Burakale, Purvesh Kewati, Prajwal Niwal, Preet Zatale, | Pharmacovigilance: A Cross-Sectional Hospital Base Research Survey on Antihypertensive Drugs and their Adverse Drug Reaction | International Journal of Scientific Development and Research | 2024, 9 (2) | Scopus |
| 8 | R.D. Jawarkar | Chemical Composition of Piper nigrum L. Cultivar Guajarina Essential Oils and Their Biological Activity |
Molecules (ISSN 1420-3049) |
2024, 29 | 4.927 |
| 9 | R.D. Jawarkar, Anam Khan | Natural compounds for oxidative stress and neuroprotection in schizophrenia composition, mechanisms, and therapeutic potential |
Nutritional Neuroscience: (ISSN 1476-8305) |
2024 | 3.6 |
| 10 | R.D. Jawarkar | Mechanistic QSAR modelling derived virtual screening, drug repurposing, ADMET and in-vitro evaluation to identify anticancer lead as lysine specific demethylase 5a inhibitor | Journal of Bimolecular Structure and Dynamics: (ISSN 1538-0254) | 2024 | 4.4 |
| 11 | Dr. Snehal Manekar, Gayatri Polakhare, Pratiksha Yawalkar | Analysis of the relative effectiveness of Curcumin loaded chitosan nanoparticles and pure Curcumin compound in the treatment of Leishmaniasis | International Journal of Pharmaceutical Quality assurance | 2024, 15(03) 1460-1465 | 1.04 |
| 12 | R.D. Jawarkar | Synthesis, in silico studies and in vitro cytotoxicity evaluation of novel posaconazole derivative as a ALK TK inhibitor |
Journal of Taibah University for Science (ISSN 1658-3655) |
2024 | 3.3 |
| 13 | R.D. Jawarkar | QSAR modelling approaches to identify a novel ACE2 inhibitor that selectively bind with the C and N terminals of the ectodomain | Journal of Bimolecular Structure and Dynamics | 2024, 2550-2569 | 4.4 |
| 14 | Dr. Pravin N. Khatale, Ekant Taywade, Rahul D. Jawarkar, Anam Khan |
An Insight into the Anti Cancer and Anti-Microbial Activity of Novel Plant Extracts from Ziziphus Spina Christi L. Against: Breast Cancer Through in Vitro Approaches |
Bioscene | December 2024 | Scopus |
| 15 | R.D. Jawarkar | Carbonylbis (hydrazine carbothioamide) derivatives as a new class of glucosidase inhibitors and their mechanistic insights via molecular docking and dynamic simulations | Archiv der Pharmazie | 2024, 2300604 | 4.3 |
| 16 | R.D. Jawarkar | QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors | Chemical Physics Impact | 2024, 100544 | 3.8 |
| 17 | Rahul D. Jawarkar | Computational Exploration of Naturally Occurring Flavonoids as TGF Inhibitors in Breast Cancer Insights from Docking and Molecular Dynamics Simulations and In vitro Cytotoxicity Study | Chemistry & Biodiversity | 2024, e202301903 | 2.7 |
| 18 | Rahul D. Jawarkar | Synthesis of the chromone thiosemicarbazone scaffold as promising glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design | Archiv der Pharmazie | 2024, 2400140 | 4.3 |
| 19 | Rahul D. Jawarkar | Synthesis and antiproliferative evaluation of novel 3, 5, 8-trisubstituted coumarins against breast cancer | Future Medicinal Chemistry | 2024, 1053-1073 | 4.2 |
| 20 | Rahul D. Jawarkar | Structural, dynamic behaviour, in-vitro and computational investigations of Schiff bases of 1, 3-diphenyl urea derivatives against SARS-CoV-2 spike protein | Scientific Reports | 2024, 12588 | 3.8 |
| 21 | Rahul D. Jawarkar | Unveiling dynamics of nitrogen content and selected nitrogen heterocycles in thrombin inhibitors: a ceteris paribus approach | Expert Opinion on Drug Discovery | 2024, 991-1009 | 6.6 |
| 22 | Rahul D. Jawarkar | Synthesis, biological evaluation, and molecular modelling of substituted thiazolyl thiourea derivatives: A new class of prolyl oligopeptidase inhibitors | International Journal of Biological Macromolecules | 2024, 133571 | 7.7 |
| 23 | Rahul D. Jawarkar | Multi-Target In-Silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors | Scientific Reports | 2024, 15991 | 3.8 |
| 24 |
Dr. Pravin N. Khatale, Dr. Prashant V. Ajmire |
Questionnaire based awareness study for adverse drug reaction reporting by the community pharmacist in Amravati district. | Asian Journal of Pharmaceutical Research | 2024 | Scopus |
| 25 | Rahul D. Jawarkar | Hydrazide Hydrazones as Potential Antitubercular Agents: An Overview of the Literature (1999-2023) | SynOpen | 2024, 173-184 | 2.0 |
| 26 | Dr. Pravin N. Khatale, Bhatkar, Tushar, Burakle, Pramod, Ajmire, Prashant, Jawarkar, Rahul, , Taywade, Ekant | RP-HPLC Method Development and Validation of Rivaroxaban in Pharmaceutical Tablet Dosage Form | Research Journal of Pharmacy and Technology | 2024, 2869-2874 | Scopus |
| 27 | Rahul D. Jawarkar | Cheminformatics approaches to predict the bioactivity and to discover the pharmacophoric traits crucial to block NF-Alpha B | Chemical Physics Impact | 9.0, 2024, 100720 | 3.8 |
| 28 | Rahul D. Jawarkar | Cheminformatics-driven prediction of BACE-1 inhibitors: Affinity and molecular mechanism exploration | Chemical Physics Impact | 9.0, 2024, 100754 | 3.8 |
| 29 | Rahul D. Jawarkar | Design, synthesis, QSAR modelling and molecular dynamic simulations of N-tosyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors | Scientific Reports | 14.0(1.0), 2024, 25754 | 3.8 |
| 30 | Dr. Ashish Wadekar | Recent advances in Management of Diabetes Mellitus: An overview | Frontiers in Health Informatics | 2024, 3(13) | Scopus |
| S.N. | Name of Author/s | Title of Publication | Journal Name | Volume, Year | Indexed /IF |
|---|---|---|---|---|---|
| 1 | Rahul D. Jawarkar | Theoretical and Anti-Klebsiella pneumoniae Evaluations of Substituted 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide and Imidazopyridine Hydrazide Derivatives | Molecules (ISSSN: 1420-3049) | 2023, 28, 2801,01/01/2015 | 4.927 |
| 2 | Dr. Pravin N. Khatale, Dr. Prashant V. Ajmire, Rahul D Jawarkar, | In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators | Front. Pharmacol (ISSN:1663-9812) | 2023, 14, 1-24 | 5.6 |
| 3 | Dr. Snehal S. Manekar | Standardization of marketed polyherbal churna | European Journal of Biomedical AND Pharmaceutical sciences (ISSN 2349-8870) | 2023, 10 (1), 336-340 | Scopus/Web of Science/ PubMed |
| 4 | Ashish B. Wadekar | An HPLC Method for Tenofovir Alafenamide Hemifumarate Estimation Driven by QbD: Development and Validation | Eur. Chem. Bull (ISSN 2063-5346) | 2023, 12(7), 4067-4083 | Scopus/Web of Science/ PubMed |
| 5 | Dr. Snehal Manekar | Biosynthesis of Silver Nanoparticles from Methanolic Extract of Cassia alata L and its Antibacterial activity | Lat. Am. J. Pharm., (ISSN 0326-2383) | 2023, 42(5), 34-41 | 0.24 |
| 6 | Rahul D. Jawarkar | Mechanistic QSAR analysis to predict the binding affinity of diverse heterocycles as selective cannabinoid 2 receptor inhibitor | Journal of Taibah University for Science (ISSN 1658-3655) | 2023, 17(1), 1-22 | 3.3 |
| 7 | Rahul D. Jawarkar | Carbonylbis(hydrazine‐1‐carbothioamide) derivatives as a new class of α‐glucosidase inhibitors and their mechanistic insights via molecular docking and dynamic simulations | Arch. Pharm. (ISSN: 0365-6233 ) | 2023, e2300604 | 4.61 |
| 8 | Rahul D. Jawarkar | Mechanistic QSAR analysis to predict the binding affinity of diverse heterocycles as selective cannabinoid 2 receptor inhibitor | Journal of Taibah University for Science ; (ISSN: 1658-3655) | 2023, 17(1) | 3.3 |
| 9 | Dr. Snehal S. Manekar | Design, Synthesis and Anti-Cancer Activity Studies of Some Novel 1,2,4 Triazole Pyrimidine Derivatives | European Chemical Bulletin ; (ISSN: 20635346) | 2023, 12(Special Issue 10), 2726 – 2733 | Scopus |
| S.N. | Name of Author/s | Title of Publication | Journal Name | Volume, Year | Indexed /IF |
|---|---|---|---|---|---|
| 1 | R D. Jawarkar | Repurposing of food molecules as a potential BACE1 inhibitor for Alzheimer’s disease | Frontiers in Aging Neuroscience (ISNN:1663-4365) | 2014-22, 01/01/2022 | 5.702 |
| 2 | Sarin A. Chavhan, Ravindra L. Bakal, Rahul D. Jawarkar, Roshani P. Gandhi, Mayuri P. Chandak and Israa Lewaa | Role of phytochemicals as potential radio protectants | Bulletin of the National Research Centre (ISNN:2522-8307) | (2022) 46:48, 01/02/2013 | Scopus/Web of Science/ PubMed |
| 3 | Rahul D. Jawarkar | Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals | Frontiers in Pharmacology (ISNN:16639812) | February 2022, Volume 12, Article 812565, 01/01/2019 | 5.988 |
| 4 | Rahul D. Jawarkar , Ravindra L. Bakal | QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA | Molecules (ISNN:1420-3049) | 2022, 27, 4758, 4-31 | 4.927 |
| 5 | Rahul D. Jawarkar, Ravindra L. Bakal | QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophore Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads | Molecules (ISNN:1420-3049) | 2022, 27, 4951, 01/02/2029 | 4.927 |
| 6 | Ravindra L. Bakal, Rahul D. Jawarkar, J.V. Manwar, Minal S. Jaiswal | Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycaemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches | Saudi Pharmaceutical Journal (ISNN:1319-0164) | 2022, 01/01/2018 | 4.562 |
| 7 | Nikita K. Gaydhane, Manisha P. More, Vinayal V.Thombale, Gayatri M. Polakhare, Ruchita R.Tale and Ravindra L. Bakal | A Review on Implementing Quality by Design | Annals of Pharma Research(ISSN: 2347-1956) | 2022, 10 (9), 718-730 | Scopus/Web of Science/ PubMed |
| 8 | Ashish B Wadekar, Jagdish V Manwar, Ravindra L Bakal, Dipak D Kumbhar | Mechanisms-and-pharmaceutical-application-of-solid-lipid-nanoparticles-as-efficient-drug-delivery-system | Sys Rev Pharm (P-ISSN 0975-8453) | 2022, 13(12), 862-869 | Scopus/Web of Science/ PubMed |
| 9 | Nikita K. Gaydhane, Manisha P. More, Dhanshree Dores, Ravindra L. Bakal | Strategic approaches for colon targeted drug delivery system an overview of recent advancement | Annals of Pharma Research (ISSN: 2347-1956) | 2022, 10 (9), 731-749 | Scopus/Web of Science/ PubMed |
| 10 | Prerna A. Patinge, Sagar N. Ande, Ravindra L. Bakal, Kajal D. Chaudhari | Microemulsion-based gels: A betterment in topical drug delivery system | Innovations in Pharmaceuticals and Pharmacotherapy (p-ISSN: 2395-0781) | 2022, 10(2), 14-18 | Scopus/Web of Science/ PubMed |
| 11 | Snehal S Manekar, Ravindrakumar L Bakal, Sarin A Chavhan, Chetan M Jain, Ankush R Turankar | Medicinal plants used in treatment and management of dengue: An overview | International Journal of Pharmaceutical Science and Research (ISSN: 2455-4685) | 2022, 7 (3), 20-29 | Scopus/Web of Science/ PubMed |
| 12 | Dr. Snehal S. Manekar | Challenges and measures during management of mounting biomedical waste in COVID‑19 pandemic: An Indian approach | Bulletin of the National Research Centre; (ISNN: 2522-8307) | (2022) 46(1):159 | SPRINGER |
| 13 | Dr. Snehal S Manekar | Enhancement of Dissolution profile of poorly water soluble drug using Water Soluble Carriers | Asian Journal of Pharmaceutical Research; (ISNN: 2231–5691) | (2022); 12(2):137-142. | |
| 14 | Rahul D. Jawarkar | Identification of concealed structural alerts using QSTR modelling for Pseudokirchneriella subcapitata | Aquatic Toxicology (ISNN:0166-445X) | 239 (2021) 105962, 01/07/2024 | 4.964 |
| 15 | Dr. Snehal S Manekar | Enhancement of Dissolution profile of poorly water soluble drug using Water Soluble Carriers | Asian Journal of Pharmaceutical Research; (ISNN: 2231–5691) | (2022); 12(2):137-142. |